dacarbazine has been researched along with Cholestasis in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balducci, N; Biolato, M; Di Napoli, N; Diletto, B; Grieco, A; Miele, L; Tafuri, MA; Vecchio, FM | 1 |
| Balakrishnan, A; Jaglal, M; Ledford, R | 1 |
| Hoorens, A; Neyns, B; Stupp, R | 1 |
| Bronder, E; Garbe, E; Herbst, H; Kauffmann, W; Klimpel, A; Orzechowski, HD; Sarganas, G; Thomae, M | 1 |
| Mohammad Alizadeh, A; Zamani, N | 1 |
| Briones, J; Bruguera, M; Cervantes, F; Font, C; Grau, JM; Montserrat, E; Rozman, C | 1 |
| Kaaden, R; Klotz, E; Wienbeck, M; Zwack, K | 1 |
2 review(s) available for dacarbazine and Cholestasis
| Article | Year |
|---|---|
Severe cholestatic hepatitis due to temozolomide: an adverse drug effect to keep in mind. Case report and review of literature.
Topics: Aged; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Cholestasis; Dacarbazine; Fatal Outcome; Glioblastoma; Humans; Male; Temozolomide | 2015 |
Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system.
Topics: Adverse Drug Reaction Reporting Systems; Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Cholestasis; Dacarbazine; Glioblastoma; Hepatitis; Humans; Male; Middle Aged; Prognosis; Temozolomide; United States; United States Food and Drug Administration | 2012 |
5 other study(ies) available for dacarbazine and Cholestasis
| Article | Year |
|---|---|
Temozolomide-induced biliary ductopenia: a case report.
Topics: Antineoplastic Agents, Alkylating; Bile Duct Diseases; Bile Ducts, Intrahepatic; Chemoradiotherapy; Cholestasis; Dacarbazine; Female; Glioblastoma; Humans; Hyperbilirubinemia; Middle Aged; Temozolomide | 2016 |
Valproic acid related idiosyncratic drug induced hepatotoxicity in a glioblastoma patient treated with temozolomide.
Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Chemotherapy, Adjuvant; Cholestasis; Dacarbazine; Glioblastoma; Humans; Liver Failure; Male; Middle Aged; Temozolomide; Valproic Acid | 2008 |
Drug-induced cholestatic hepatitis: how late can it occur even after the cessation of the culpable drug?
Topics: Acetaminophen; Analgesics, Non-Narcotic; Antineoplastic Agents, Alkylating; Chemical and Drug Induced Liver Injury; Cholestasis; Dacarbazine; Drug Therapy, Combination; Glioblastoma; Humans; Male; Middle Aged; Prognosis; Temozolomide | 2012 |
Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cholestasis; Dacarbazine; Diagnosis, Differential; Doxorubicin; Female; Fever; Hodgkin Disease; Humans; Incidence; Liver; Liver Function Tests; Male; Mechlorethamine; Prednisone; Procarbazine; Remission Induction; Survival Analysis; Vinblastine; Vincristine | 1996 |
[Icteric cholestasis as an early symptom in Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Cholestasis; Cyclophosphamide; Dacarbazine; Diagnosis, Differential; Doxorubicin; Hodgkin Disease; Humans; Ilium; Liver; Lymph Nodes; Lymphatic Metastasis; Male; Prednisone; Procarbazine; Pruritus; Salmonella Infections; Time Factors; Vinblastine; Vincristine | 1990 |